| Literature DB >> 26869333 |
Binbin Guan1, Wenyi Li2, Fengying Li2, Yun Xie2, Qicheng Ni2, Yanyun Gu2, Xiaoying Li2, Qidi Wang2, Hongli Zhang3, Guang Ning2.
Abstract
The cellular and molecular mechanisms of glucose-stimulated β-cell proliferation are poorly understood. Recently, secreted frizzled-related protein 5 (encoded by Sfrp5; a Wnt signaling inhibitor) has been demonstrated to be involved in β-cell proliferation in obesity. A previous study demonstrated that glucose enhanced Wnt signaling to promote cell proliferation. We hypothesized that inhibition of SFRP5 contributes to glucose-stimulated β-cell proliferation. In this study, we found that the Sfrp5 level was significantly reduced in high glucose-treated INS-1 cells, primary rat β-cells, and islets isolated from glucose-infused rats. Overexpression of SFRP5 diminished glucose-stimulated proliferation in both INS-1 cells and primary β-cells, with a concomitant inhibition of the Wnt signaling pathway and decreased cyclin D2 expression. In addition, we showed that glucose-induced Sfrp5 suppression was modulated by the PI3K/AKT pathway. Therefore, we conclude that glucose inhibits Sfrp5 expression via the PI3K/AKT pathway and hence promotes rat pancreatic β-cell proliferation.Entities:
Keywords: Sfrp5; glucose; proliferation; β-cell
Mesh:
Substances:
Year: 2016 PMID: 26869333 DOI: 10.1530/JOE-15-0535
Source DB: PubMed Journal: J Endocrinol ISSN: 0022-0795 Impact factor: 4.286